[ACRS] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 16.18%
YoY- 58.51%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 1,580 1,449 2,046 1,407 1,095 983 5,865 -58.12%
PBT -13,779 -10,659 -11,570 -15,328 -19,177 -23,138 -49,876 -57.41%
Tax -182 -591 27 -318 -32,181 32,733 18,504 -
NP -13,173 -10,659 -11,597 -15,586 -18,594 -55,319 -49,876 -58.66%
Tax Rate - - - - - - - -
Total Cost 14,753 12,108 13,643 16,993 19,689 56,302 55,741 -58.61%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -833.73 -735.61 -566.81 -1,107.75 -1,698.08 -5,627.57 -850.40 -1.30%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.30 -0.25 -0.28 -0.37 -0.45 -1.34 -1.21 -60.36%
EPS Diluted -0.30 -0.25 -0.28 -0.37 -0.45 -1.34 -1.21 -60.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.